Observational Registry of Treatment Patterns in U.S. Heart Failure Patients with Reduced Ejection Fraction

Project: Other project

StatusActive
Effective start/end date7/7/165/24/20

Funding

  • Novartis Pharmaceuticals Corporation: $52,959.24